位置:首页 > 蛋白库 > EIF2D_HUMAN
EIF2D_HUMAN
ID   EIF2D_HUMAN             Reviewed;         584 AA.
AC   P41214; Q5SY40; Q8IXV3; Q96DG3; Q96TG7; Q9NR27; Q9NSN0; Q9NV18; Q9NZ21;
DT   01-FEB-1995, integrated into UniProtKB/Swiss-Prot.
DT   21-AUG-2007, sequence version 3.
DT   03-AUG-2022, entry version 188.
DE   RecName: Full=Eukaryotic translation initiation factor 2D;
DE            Short=eIF2d;
DE   AltName: Full=Hepatocellular carcinoma-associated antigen 56;
DE   AltName: Full=Ligatin;
GN   Name=EIF2D; Synonyms=HCA56, LGTN;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), IDENTIFICATION BY MASS
RP   SPECTROMETRY, FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=20566627; DOI=10.1074/jbc.m110.119693;
RA   Dmitriev S.E., Terenin I.M., Andreev D.E., Ivanov P.A., Dunaevsky J.E.,
RA   Merrick W.C., Shatsky I.N.;
RT   "GTP-independent tRNA delivery to the ribosomal P-site by a novel
RT   eukaryotic translation factor.";
RL   J. Biol. Chem. 285:26779-26787(2010).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Hepatoma;
RX   PubMed=12097419; DOI=10.4049/jimmunol.169.2.1102;
RA   Wang Y., Han K.-J., Pang X.-W., Vaughan H.A., Qu W., Dong X.-Y.,
RA   Peng J.-R., Zhao H.-T., Rui J.-A., Leng X.-S., Cebon J., Burgess A.W.,
RA   Chen W.-F.;
RT   "Large scale identification of human hepatocellular carcinoma-associated
RT   antigens by autoantibodies.";
RL   J. Immunol. 169:1102-1109(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Cervix, Lymph, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 196-584 (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 234-308.
RX   PubMed=2482295; DOI=10.1242/jcs.93.2.227;
RA   Jakoi E.R., Brown A.L., Ho Y.S., Snyderman R.;
RT   "Molecular cloning of the cDNA for ligatin.";
RL   J. Cell Sci. 93:227-232(1989).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [11]
RP   FUNCTION.
RX   PubMed=20713520; DOI=10.1101/gad.1957510;
RA   Skabkin M.A., Skabkina O.V., Dhote V., Komar A.A., Hellen C.U.,
RA   Pestova T.V.;
RT   "Activities of ligatin and MCT-1/DENR in eukaryotic translation initiation
RT   and ribosomal recycling.";
RL   Genes Dev. 24:1787-1801(2010).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-237, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-237 AND SER-361, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- FUNCTION: Translation initiation factor that is able to deliver tRNA to
CC       the P-site of the eukaryotic ribosome in a GTP-independent manner. The
CC       binding of Met-tRNA(I) occurs after the AUG codon finds its position in
CC       the P-site of 40S ribosomes, the situation that takes place during
CC       initiation complex formation on some specific RNAs. Its activity in
CC       tRNA binding with 40S subunits does not require the presence of the
CC       aminoacyl moiety. Possesses the unique ability to deliver non-Met
CC       (elongator) tRNAs into the P-site of the 40S subunit. In addition to
CC       its role in initiation, can promote release of deacylated tRNA and mRNA
CC       from recycled 40S subunits following ABCE1-mediated dissociation of
CC       post-termination ribosomal complexes into subunits.
CC       {ECO:0000269|PubMed:20566627, ECO:0000269|PubMed:20713520}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:20566627}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P41214-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P41214-2; Sequence=VSP_006300;
CC   -!- DEVELOPMENTAL STAGE: Found during embryonic development and in early
CC       differentiated states.
CC   -!- SIMILARITY: Belongs to the eIF2D family. {ECO:0000305}.
CC   -!- CAUTION: Was previously erroneously called ligatin, a trafficking
CC       receptor for phosphoglycoproteins, while ligatin is actually a distinct
CC       10 kDa filamentous membrane protein encoded by a still unidentified
CC       gene. {ECO:0000305|PubMed:20566627}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF220417; AAF34185.2; -; mRNA.
DR   EMBL; AF262403; AAF74205.1; -; mRNA.
DR   EMBL; AK001852; BAA91942.1; -; mRNA.
DR   EMBL; AL591846; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471100; EAW93536.1; -; Genomic_DNA.
DR   EMBL; CH471100; EAW93540.1; -; Genomic_DNA.
DR   EMBL; BC001585; AAH01585.1; -; mRNA.
DR   EMBL; BC039134; AAH39134.2; -; mRNA.
DR   EMBL; BC058905; AAH58905.1; -; mRNA.
DR   EMBL; AL162001; CAB82330.1; -; mRNA.
DR   EMBL; AF159586; AAD41909.1; -; mRNA.
DR   CCDS; CCDS1465.1; -. [P41214-1]
DR   CCDS; CCDS55680.1; -. [P41214-2]
DR   PIR; A60697; A60697.
DR   PIR; T47178; T47178.
DR   RefSeq; NP_001188407.1; NM_001201478.1. [P41214-2]
DR   RefSeq; NP_008824.2; NM_006893.2. [P41214-1]
DR   PDB; 5OA3; EM; 4.30 A; 0=1-584.
DR   PDB; 5OA9; X-ray; 1.80 A; A=380-584.
DR   PDB; 5W2F; X-ray; 1.40 A; A=380-584.
DR   PDBsum; 5OA3; -.
DR   PDBsum; 5OA9; -.
DR   PDBsum; 5W2F; -.
DR   AlphaFoldDB; P41214; -.
DR   SMR; P41214; -.
DR   BioGRID; 108259; 36.
DR   IntAct; P41214; 5.
DR   MINT; P41214; -.
DR   STRING; 9606.ENSP00000271764; -.
DR   iPTMnet; P41214; -.
DR   MetOSite; P41214; -.
DR   PhosphoSitePlus; P41214; -.
DR   BioMuta; EIF2D; -.
DR   DMDM; 158957575; -.
DR   EPD; P41214; -.
DR   jPOST; P41214; -.
DR   MassIVE; P41214; -.
DR   MaxQB; P41214; -.
DR   PaxDb; P41214; -.
DR   PeptideAtlas; P41214; -.
DR   PRIDE; P41214; -.
DR   ProteomicsDB; 55417; -. [P41214-1]
DR   ProteomicsDB; 55418; -. [P41214-2]
DR   Antibodypedia; 34586; 122 antibodies from 26 providers.
DR   DNASU; 1939; -.
DR   Ensembl; ENST00000271764.7; ENSP00000271764.2; ENSG00000143486.16. [P41214-1]
DR   Ensembl; ENST00000367114.7; ENSP00000356081.3; ENSG00000143486.16. [P41214-2]
DR   GeneID; 1939; -.
DR   KEGG; hsa:1939; -.
DR   MANE-Select; ENST00000271764.7; ENSP00000271764.2; NM_006893.3; NP_008824.2.
DR   UCSC; uc001heh.4; human. [P41214-1]
DR   CTD; 1939; -.
DR   DisGeNET; 1939; -.
DR   GeneCards; EIF2D; -.
DR   HGNC; HGNC:6583; EIF2D.
DR   HPA; ENSG00000143486; Low tissue specificity.
DR   MIM; 613709; gene.
DR   neXtProt; NX_P41214; -.
DR   OpenTargets; ENSG00000143486; -.
DR   PharmGKB; PA30355; -.
DR   VEuPathDB; HostDB:ENSG00000143486; -.
DR   eggNOG; KOG2522; Eukaryota.
DR   GeneTree; ENSGT00550000074865; -.
DR   HOGENOM; CLU_012487_2_0_1; -.
DR   InParanoid; P41214; -.
DR   OMA; MFLKPYR; -.
DR   OrthoDB; 401807at2759; -.
DR   PhylomeDB; P41214; -.
DR   TreeFam; TF105830; -.
DR   PathwayCommons; P41214; -.
DR   SignaLink; P41214; -.
DR   BioGRID-ORCS; 1939; 18 hits in 1082 CRISPR screens.
DR   ChiTaRS; EIF2D; human.
DR   GeneWiki; LGTN; -.
DR   GenomeRNAi; 1939; -.
DR   Pharos; P41214; Tbio.
DR   PRO; PR:P41214; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; P41214; protein.
DR   Bgee; ENSG00000143486; Expressed in left ovary and 194 other tissues.
DR   ExpressionAtlas; P41214; baseline and differential.
DR   Genevisible; P41214; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0016604; C:nuclear body; IDA:HPA.
DR   GO; GO:0003723; F:RNA binding; IEA:InterPro.
DR   GO; GO:0038023; F:signaling receptor activity; TAS:ProtInc.
DR   GO; GO:0003743; F:translation initiation factor activity; IDA:UniProtKB.
DR   GO; GO:0001731; P:formation of translation preinitiation complex; IDA:UniProtKB.
DR   GO; GO:0006886; P:intracellular protein transport; TAS:ProtInc.
DR   GO; GO:0075522; P:IRES-dependent viral translational initiation; IDA:UniProtKB.
DR   GO; GO:0032790; P:ribosome disassembly; IDA:UniProtKB.
DR   CDD; cd11608; eIF2D_C; 1.
DR   DisProt; DP02704; -.
DR   InterPro; IPR039757; EIF2D.
DR   InterPro; IPR039759; eIF2D_SUI1.
DR   InterPro; IPR041366; Pre-PUA.
DR   InterPro; IPR002478; PUA.
DR   InterPro; IPR015947; PUA-like_sf.
DR   InterPro; IPR001950; SUI1.
DR   InterPro; IPR036877; SUI1_dom_sf.
DR   InterPro; IPR036885; SWIB_MDM2_dom_sf.
DR   InterPro; IPR003121; SWIB_MDM2_domain.
DR   PANTHER; PTHR12217; PTHR12217; 1.
DR   Pfam; PF17832; Pre-PUA; 1.
DR   Pfam; PF01253; SUI1; 1.
DR   SMART; SM00359; PUA; 1.
DR   SUPFAM; SSF47592; SSF47592; 1.
DR   SUPFAM; SSF55159; SSF55159; 1.
DR   SUPFAM; SSF88697; SSF88697; 1.
DR   PROSITE; PS50890; PUA; 1.
DR   PROSITE; PS50296; SUI1; 1.
DR   PROSITE; PS51925; SWIB_MDM2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Cytoplasm;
KW   Initiation factor; Phosphoprotein; Protein biosynthesis;
KW   Reference proteome.
FT   CHAIN           1..584
FT                   /note="Eukaryotic translation initiation factor 2D"
FT                   /id="PRO_0000130611"
FT   DOMAIN          93..173
FT                   /note="PUA"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00161"
FT   DOMAIN          383..467
FT                   /note="SWIB/MDM2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01273"
FT   DOMAIN          491..564
FT                   /note="SUI1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00200"
FT   REGION          223..257
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        223..242
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        243..257
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0007744|PubMed:22814378"
FT   MOD_RES         237
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         254
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q61211"
FT   MOD_RES         361
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   VAR_SEQ         177..300
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:12097419"
FT                   /id="VSP_006300"
FT   VARIANT         210
FT                   /note="T -> I (in dbSNP:rs35252702)"
FT                   /id="VAR_052507"
FT   CONFLICT        11
FT                   /note="N -> D (in Ref. 3; BAA91942)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        66
FT                   /note="S -> N (in Ref. 2; AAF34185/AAF74205)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        210
FT                   /note="T -> N (in Ref. 2; AAF34185)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        304..308
FT                   /note="GRQLD -> DDNWT (in Ref. 8; AAD41909)"
FT                   /evidence="ECO:0000305"
FT   STRAND          382..386
FT                   /evidence="ECO:0007829|PDB:5W2F"
FT   HELIX           389..391
FT                   /evidence="ECO:0007829|PDB:5W2F"
FT   HELIX           392..395
FT                   /evidence="ECO:0007829|PDB:5W2F"
FT   TURN            396..399
FT                   /evidence="ECO:0007829|PDB:5W2F"
FT   HELIX           408..421
FT                   /evidence="ECO:0007829|PDB:5W2F"
FT   STRAND          432..434
FT                   /evidence="ECO:0007829|PDB:5W2F"
FT   HELIX           437..443
FT                   /evidence="ECO:0007829|PDB:5W2F"
FT   HELIX           446..448
FT                   /evidence="ECO:0007829|PDB:5OA9"
FT   TURN            449..451
FT                   /evidence="ECO:0007829|PDB:5OA9"
FT   STRAND          454..456
FT                   /evidence="ECO:0007829|PDB:5W2F"
FT   HELIX           457..467
FT                   /evidence="ECO:0007829|PDB:5W2F"
FT   STRAND          468..474
FT                   /evidence="ECO:0007829|PDB:5W2F"
FT   STRAND          482..486
FT                   /evidence="ECO:0007829|PDB:5W2F"
FT   STRAND          491..499
FT                   /evidence="ECO:0007829|PDB:5W2F"
FT   STRAND          502..508
FT                   /evidence="ECO:0007829|PDB:5W2F"
FT   HELIX           510..513
FT                   /evidence="ECO:0007829|PDB:5W2F"
FT   HELIX           517..528
FT                   /evidence="ECO:0007829|PDB:5W2F"
FT   STRAND          532..536
FT                   /evidence="ECO:0007829|PDB:5W2F"
FT   STRAND          538..541
FT                   /evidence="ECO:0007829|PDB:5W2F"
FT   STRAND          544..550
FT                   /evidence="ECO:0007829|PDB:5W2F"
FT   HELIX           553..561
FT                   /evidence="ECO:0007829|PDB:5W2F"
FT   HELIX           568..570
FT                   /evidence="ECO:0007829|PDB:5W2F"
FT   STRAND          571..573
FT                   /evidence="ECO:0007829|PDB:5W2F"
FT   HELIX           574..576
FT                   /evidence="ECO:0007829|PDB:5W2F"
SQ   SEQUENCE   584 AA;  64706 MW;  C302B63268231154 CRC64;
     MFAKAFRVKS NTAIKGSDRR KLRADVTTAF PTLGTDQVSE LVPGKEELNI VKLYAHKGDA
     VTVYVSGGNP ILFELEKNLY PTVYTLWSYP DLLPTFTTWP LVLEKLVGGA DLMLPGLVMP
     PAGLPQVQKG DLCAISLVGN RAPVAIGVAA MSTAEMLTSG LKGRGFSVLH TYQDHLWRSG
     NKSSPPSIAP LALDSADLSE EKGSVQMDST LQGDMRHMTL EGEEENGEVH QAREDKSLSE
     APEDTSTRGL NQDSTDSKTL QEQMDELLQQ CFLHALKCRV KKADLPLLTS TFLGSHMFSC
     CPEGRQLDIK KSSYKKLSKF LQQMQQEQII QVKELSKGVE SIVAVDWKHP RITSFVIPEP
     SPTSQTIQEG SREQPYHPPD IKPLYCVPAS MTLLFQESGH KKGSFLEGSE VRTIVINYAK
     KNDLVDADNK NLVRLDPILC DCILEKNEQH TVMKLPWDSL LTRCLEKLQP AYQVTLPGQE
     PIVKKGRICP IDITLAQRAS NKKVTVVRNL EAYGLDPYSV AAILQQRCQA STTVNPAPGA
     KDSLQVQIQG NQVHHLGWLL LEEYQLPRKH IQGLEKALKP GKKK
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024